国：米国 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
米国 (1012)
- {{country.name}}
- すべての国
- 米国 (1012)
- オーストラリア (58)
- オーストリア (16)
- ベルギー (7)
- ブラジル (16)
- カナダ (83)
- 中国 (94)
- デンマーク (6)
- フィンランド (4)
- フランス (41)
- ドイツ (738)
- 香港 (46)
- インド (19)
- アイルランド (1)
- イスラエル (19)
- イタリア (4)
- 日本 (37)
- メキシコ (28)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (14)
- ポーランド (9)
- ロシア (2)
- 韓国 (12)
- スペイン (4)
- スウェーデン (70)
- スイス (11)
- 台湾 (67)
- タイ (2)
- トルコ (1)
- イギリス (69)
全取引所
バイオテクノロジー (1012)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S NONOF | $67 — |
+0.9
|
$306.33B — | $700 — | $64.6 — | $67 — | $306.33B — | 19.53 | $3.43 — | |
| Novo Nordisk A/S NVO | $67.7 — |
-0.06
|
$302.6B — | $17.78M — | $64.04 — | $67.75 — | $302.6B — | 19.74 | $3.43 — | |
| Vertex Pharmaceuticals Incorporated VRTX | $439.37 — |
+3.38
|
$112.83B — | $1.97M — | $423.2 — | $441.1 — | $112.83B — | 0 | -$3.83 — | |
| CSL Limited CSLLY | $75.46 — |
-1.77
|
$74.03B — | $20.33K — | $75.44 — | $75.83 — | $74.03B — | 27.74 | $2.72 — | |
| Regeneron Pharmaceuticals REGN | $575.63 — |
+9.07
|
$62.15B — | $1.9M — | $535.73 — | $577.99 — | $62.15B — | 14.63 | $39.32 — | |
| argenx SE ARGX | $560.9 — |
+2.05
|
$35.24B — | $657.91K — | $535.5 — | $561.48 — | $35.24B — | 43.92 | $12.77 — | |
| Alnylam Pharmaceuticals ALNY | $270.19 — |
+7.58
|
$35.23B — | $1.22M — | $252.79 — | $270.2 — | $35.23B — | 0 | -$2.1 — | |
| UCB SA UCBJY | $88.24 — |
+1.67
|
$34.82B — | $2.92K — | $85.86 — | $88.24 — | $34.82B — | 28.46 | $3.1 — | |
| BioNTech SE BNTX | $97.27 — |
+4.85
|
$23.38B — | $767.74K — | $93.94 — | $97.44 — | $23.38B — | 0 | -$3.61 — | |
| Royalty Pharma RPRX | $33.35 — |
+0.6
|
$19.15B — | $5.47M — | $32.57 — | $33.6 — | $19.15B — | 17.46 | $1.91 — | |
| Summit Therapeutics SMMT | $25.26 — |
+5.43
|
$18.76B — | $3.02M — | $23.26 — | $25.3 — | $18.76B — | 0 | -$0.34 — | |
| United Therapeutics UTHR | $310.8 — |
+3.11
|
$14.02B — | $330.27K — | $304.25 — | $312.48 — | $14.02B — | 12.37 | $25.11 — | |
| Genmab A/S GMAB | $19.93 — |
+2.94
|
$12.48B — | $2.59M — | $19.12 — | $19.95 — | $12.48B — | 10.83 | $1.84 — | |
| Insmed Incorporated INSM | $67.75 — |
+4.1
|
$12.32B — | $2.97M — | $65.1 — | $68.51 — | $12.32B — | 0 | -$5.57 — | |
| WuXi Biologics (Cayman) WXXWY | $5.93 — |
+1.19
|
$12.06B — | $5.21K — | $5.86 — | $6.15 — | $12.06B — | 28.23 | $0.21 — | |
| Incyte INCY | $60.85 — |
+3.17
|
$11.78B — | $2.01M — | $59.74 — | $61.41 — | $11.78B — | 304.25 | $0.2 — | |
| BioMarin Pharmaceutical BMRN | $61.37 — |
+4.26
|
$11.77B — | $1.63M — | $59.6 — | $62.28 — | $11.77B — | 22.72 | $2.7 — | |
| Exelixis EXEL | $36.98 — |
+2.24
|
$10.19B — | $2.65M — | $36.23 — | $37.29 — | $10.19B — | 21.01 | $1.76 — | |
| Moderna MRNA | $25.7 — |
+5.98
|
$9.94B — | $12.51M — | $24.86 — | $26.17 — | $9.94B — | 0 | -$8.73 — | |
| Ascendis Pharma A/S ASND | $154.43 — |
+2.1
|
$9.32B — | $438.97K — | $152.45 — | $158.33 — | $9.32B — | 0 | -$6.57 — | |
| Verona Pharma VRNA | $67.53 — |
+6.65
|
$9B — | $1.41M — | $60.5 — | $68.36 — | $9B — | 0 | -$2 — | |
| Bio-Techne TECH | $53.9 — |
+7.93
|
$8.52B — | $3.27M — | $51.53 — | $54.4 — | $8.52B — | 64.93 | $0.83 — | |
| Halozyme Therapeutics HALO | $66.58 — |
+1.08
|
$8.2B — | $2.57M — | $64.05 — | $67.9 — | $8.2B — | 17.70 | $3.76 — | |
| Roivant Sciences ROIV | $10.99 — |
+3.29
|
$7.84B — | $4.79M — | $10.58 — | $11.06 — | $7.84B — | 0 | -$1 — | |
| Revolution Medicines RVMD | $41.88 — |
+3.61
|
$7.8B — | $1.55M — | $41.07 — | $42.6 — | $7.8B — | 0 | -$3.58 — | |
| Corcept Therapeutics Incorporated CORT | $72.14 — |
+2.72
|
$7.65B — | $1.16M — | $69.33 — | $73.36 — | $7.65B — | 62.73 | $1.15 — | |
| BridgeBio Pharma BBIO | $35.68 — |
+4.42
|
$6.77B — | $3.24M — | $34.26 — | $36.1 — | $6.77B — | 0 | -$3.56 — | |
| Madrigal Pharmaceuticals MDGL | $300.76 — |
+2.08
|
$6.68B — | $241.14K — | $297.78 — | $307.54 — | $6.68B — | 0 | -$17.83 — | |
| Blueprint Medicines BPMC | $100.31 — |
+3.23
|
$6.48B — | $717.7K — | $97.4 — | $101.92 — | $6.48B — | 0 | -$2.51 — | |
| Jazz Pharmaceuticals JAZZ | $103.58 — |
+5.93
|
$6.38B — | $1.66M — | $99.15 — | $105.28 — | $6.38B — | 14.07 | $7.36 — | |
| Legend Biotech LEGN | $32.38 — |
+1.89
|
$5.95B — | $1.72M — | $31.83 — | $33.3 — | $5.95B — | 0 | -$0.96 — | |
| Telix Pharmaceuticals TLPPF | $17 — |
-1.45
|
$5.69B — | $420 — | $17 — | $17 — | $5.69B — | 188.88 | $0.09 — | |
| TG Therapeutics TGTX | $34.99 — |
+4.01
|
$5.56B — | $2.79M — | $33.35 — | $35.3 — | $5.56B — | 139.96 | $0.25 — | |
| Axsome Therapeutics AXSM | $110.16 — |
+2.23
|
$5.42B — | $556.21K — | $106.01 — | $110.95 — | $5.42B — | 0 | -$5.76 — | |
| Ionis Pharmaceuticals IONS | $33.53 — |
+3.94
|
$5.34B — | $1.43M — | $32.6 — | $33.94 — | $5.34B — | 0 | -$2.99 — | |
| Nuvalent NUVL | $73.63 — |
+5.41
|
$5.29B — | $501.78K — | $70.55 — | $74.99 — | $5.29B — | 0 | -$3.93 — | |
| ADMA Biologics ADMA | $20.45 — |
+2.35
|
$4.88B — | $4.52M — | $19.66 — | $20.82 — | $4.88B — | 25.24 | $0.81 — | |
| Vaxcyte PCVX | $31.59 — |
+1.38
|
$4.08B — | $2.13M — | $31.42 — | $32.99 — | $4.08B — | 0 | -$3.8 — | |
| Krystal Biotech KRYS | $139.43 — |
+5.48
|
$4.03B — | $328.35K — | $133.09 — | $140.21 — | $4.03B — | 33.43 | $4.17 — | |
| Cytokinetics, Incorporated CYTK | $32.13 — |
+1.37
|
$3.84B — | $2.2M — | $31.71 — | $33.36 — | $3.84B — | 0 | -$5.29 — | |
| Soleno Therapeutics SLNO | $76.7 — |
-0.1
|
$3.83B — | $614.89K — | $76.28 — | $78.98 — | $3.83B — | 0 | -$4.38 — | |
| Rhythm Pharmaceuticals RYTM | $58.97 — |
+2.76
|
$3.75B — | $561.97K — | $57.85 — | $59.98 — | $3.75B — | 0 | -$4.34 — | |
| PTC Therapeutics PTCT | $46.01 — |
+4.02
|
$3.65B — | $1.54M — | $45.09 — | $46.66 — | $3.65B — | 7.06 | $6.51 — | |
| Sarepta Therapeutics SRPT | $36.37 — |
+0.28
|
$3.57B — | $6.02M — | $36.21 — | $39.21 — | $3.57B — | 0 | -$2.64 — | |
| Avidity Biosciences RNA | $29.33 — |
+5.24
|
$3.53B — | $1.45M — | $28.48 — | $31.2 — | $3.53B — | 0 | -$2.89 — | |
| SpringWorks Therapeutics SWTX | $46.12 — |
-0.3
|
$3.46B — | $8.31M — | $46.05 — | $46.21 — | $3.46B — | 0 | -$3.48 — | |
| Ultragenyx Pharmaceutical RARE | $36.09 — |
+2.79
|
$3.41B — | $1.42M — | $35.97 — | $37.27 — | $3.41B — | 0 | -$6.29 — | |
| Zai Lab ZLAB | $29.4 — |
+0.55
|
$3.32B — | $851.01K — | $28.77 — | $30 — | $3.32B — | 0 | -$2.6 — | |
| Akero Therapeutics AKRO | $41.53 — |
+4.22
|
$3.31B — | $1.55M — | $40.06 — | $42.18 — | $3.31B — | 0 | -$3.75 — | |
| Arcellx ACLX | $59.5 — |
+3.39
|
$3.28B — | $625.77K — | $59.37 — | $62.72 — | $3.28B — | 0 | -$2 — | |
| CRISPR Therapeutics AG CRSP | $37.59 — |
+5.53
|
$3.25B — | $1.96M — | $36.26 — | $38.02 — | $3.25B — | 0 | -$4.34 — | |
| Viking Therapeutics VKTX | $28.3 — |
+2.72
|
$3.18B — | $3.72M — | $27.68 — | $28.98 — | $3.18B — | 0 | -$1.16 — | |
| Crinetics Pharmaceuticals CRNX | $33.32 — |
+8.6
|
$3.12B — | $1.11M — | $31.24 — | $33.58 — | $3.12B — | 0 | -$3.69 — | |
| Scholar Rock Holding SRRK | $32.46 — |
+5.84
|
$3.08B — | $820.21K — | $31.44 — | $32.71 — | $3.08B — | 0 | -$2.47 — | |
| Merus MRUS | $42.41 — |
+3.69
|
$2.93B — | $735.69K — | $42 — | $43.37 — | $2.93B — | 0 | -$3.35 — | |
| ACADIA Pharmaceuticals ACAD | $17.52 — |
+0.46
|
$2.92B — | $2.29M — | $16.86 — | $18.09 — | $2.92B — | 12.88 | $1.36 — | |
| Catalyst Pharmaceuticals CPRX | $23.83 — |
+1.97
|
$2.91B — | $1.09M — | $23.19 — | $24.08 — | $2.91B — | 18.19 | $1.31 — | |
| Protagonist Therapeutics PTGX | $45.27 — |
+5.35
|
$2.81B — | $988.34K — | $43.75 — | $45.83 — | $2.81B — | 58.03 | $0.78 — | |
| Xenon Pharmaceuticals XENE | $35.85 — |
+2.37
|
$2.75B — | $1.18M — | $35.56 — | $36.96 — | $2.75B — | 0 | -$3.01 — | |
| Immunovant IMVT | $14.55 — |
+3.78
|
$2.47B — | $1.02M — | $14.39 — | $15.17 — | $2.47B — | 0 | -$2.62 — | |
| Veracyte VCYT | $30.76 — |
+3.53
|
$2.41B — | $1.06M — | $29.82 — | $31.36 — | $2.41B — | 99.22 | $0.31 — | |
| Mirum Pharmaceuticals MIRM | $45.57 — |
+2.94
|
$2.25B — | $373.07K — | $44.86 — | $46.23 — | $2.25B — | 0 | -$1.85 — | |
| Apellis Pharmaceuticals APLS | $17.52 — |
+1.27
|
$2.2B — | $2.94M — | $17.27 — | $18.05 — | $2.2B — | 0 | -$1.6 — | |
| BioCryst Pharmaceuticals BCRX | $10.34 — |
+3.71
|
$2.16B — | $5.52M — | $10.07 — | $10.49 — | $2.16B — | 0 | -$0.26 — | |
| Denali Therapeutics DNLI | $14.8 — |
+2.99
|
$2.15B — | $1.49M — | $14.64 — | $15.56 — | $2.15B — | 0 | -$2.67 — | |
| Vericel VCEL | $42.65 — |
+2.2
|
$2.14B — | $638.33K — | $41.97 — | $44.27 — | $2.14B — | 213.25 | $0.2 — | |
| Biohaven BHVN | $20.56 — |
+1.58
|
$2.1B — | $1.58M — | $20.02 — | $22.05 — | $2.1B — | 0 | -$9.28 — | |
| Kymera Therapeutics KYMR | $32.17 — |
+6.98
|
$2.09B — | $658.28K — | $30.51 — | $33.71 — | $2.09B — | 0 | -$2.98 — | |
| ImmunityBio IBRX | $2.36 — |
+14.01
|
$2.08B — | $12.68M — | $2.2 — | $2.46 — | $2.08B — | 0 | -$0.62 — | |
| Ligand Pharmaceuticals Incorporated LGND | $106.38 — |
+1.82
|
$2.05B — | $138.3K — | $104.65 — | $108.76 — | $2.05B — | 0 | -$0.22 — | |
| Harmony Biosciences HRMY | $35.65 — |
+4.7
|
$2.05B — | $958.56K — | $34.32 — | $35.76 — | $2.05B — | 13.60 | $2.62 — | |
| Kiniksa Pharmaceuticals KNSA | $26.84 — |
+3.11
|
$1.96B — | $287.98K — | $26.25 — | $26.91 — | $1.96B — | 0 | -$0.24 — | |
| Bavarian Nordic A/S BVNRY | $8.25 — |
+0.36
|
$1.93B — | $3.89K — | $8.22 — | $8.35 — | $1.93B — | 12.89 | $0.64 — | |
| Arrowhead Pharmaceuticals ARWR | $13.97 — |
+7.21
|
$1.92B — | $1.87M — | $13.42 — | $14.4 — | $1.92B — | 0 | -$5.15 — | |
| Travere Therapeutics TVTX | $21.54 — |
+7.59
|
$1.91B — | $1.29M — | $20.4 — | $21.8 — | $1.91B — | 0 | -$2.78 — | |
| Amicus Therapeutics FOLD | $6.21 — |
+3.85
|
$1.91B — | $6.7M — | $6.09 — | $6.31 — | $1.91B — | 0 | -$0.09 — | |
| Recursion Pharmaceuticals RXRX | $4.64 — |
+7.16
|
$1.89B — | $24.14M — | $4.41 — | $4.68 — | $1.89B — | 0 | -$1.8 — | |
| Oxford Nanopore ONTTF | $1.79 — |
+4.07
|
$1.86B — | $24.2K — | $1.72 — | $1.74 — | $1.86B — | 0 | -$0.21 — | |
| Tarsus Pharmaceuticals TARS | $44.2 — |
-1.25
|
$1.86B — | $865.11K — | $44.12 — | $46.25 — | $1.86B — | 0 | -$2.7 — | |
| Beam Therapeutics BEAM | $18.24 — |
+4.77
|
$1.83B — | $2.08M — | $17.84 — | $19.15 — | $1.83B — | 0 | -$4.61 — | |
| Centessa Pharmaceuticals CNTA | $13.15 — |
+6.91
|
$1.76B — | $406.2K — | $12.39 — | $13.35 — | $1.76B — | 0 | -$2.06 — | |
| Arcutis Biotherapeutics ARQT | $14.39 — |
+6.36
|
$1.72B — | $2.26M — | $13.5 — | $14.61 — | $1.72B — | 0 | -$1.16 — | |
| Galapagos GLPG | $25.07 — |
-0.99
|
$1.72B — | $323.65K — | $25.02 — | $25.43 — | $1.72B — | 0 | -$3.09 — | |
| Agios Pharmaceuticals AGIO | $29.14 — |
+6.66
|
$1.69B — | $463.96K — | $28.42 — | $29.39 — | $1.69B — | 2.52 | $11.54 — | |
| IDEAYA Biosciences IDYA | $18.35 — |
+5.34
|
$1.61B — | $1.33M — | $17.87 — | $18.76 — | $1.61B — | 0 | -$3.65 — | |
| Edgewise Therapeutics EWTX | $14.82 — |
+1.65
|
$1.56B — | $1.37M — | $14.68 — | $15.82 — | $1.56B — | 0 | -$1.45 — | |
| Janux Therapeutics JANX | $26.06 — |
+1.96
|
$1.54B — | $1.44M — | $25.38 — | $27.17 — | $1.54B — | 0 | -$1.28 — | |
| Immunocore IMCR | $29.54 — |
+4.01
|
$1.48B — | $264.92K — | $28.25 — | $29.65 — | $1.48B — | 0 | -$1.02 — | |
| MannKind MNKD | $4.81 — |
+5.48
|
$1.46B — | $2.5M — | $4.52 — | $4.83 — | $1.46B — | 48.10 | $0.1 — | |
| Mesoblast Limited MESO | $11.35 — |
+3.46
|
$1.46B — | $98.44K — | $11.12 — | $11.47 — | $1.46B — | 0 | -$0.91 — | |
| Adaptive Biotechnologies ADPT | $9.51 — |
+5.32
|
$1.44B — | $1.62M — | $9.1 — | $9.81 — | $1.44B — | 0 | -$0.95 — | |
| Vera Therapeutics VERA | $22.49 — |
+3.59
|
$1.43B — | $632.26K — | $22.43 — | $23.02 — | $1.43B — | 0 | -$2.75 — | |
| Dyne Therapeutics DYN | $12.56 — |
+10.08
|
$1.43B — | $4.78M — | $11.64 — | $13.03 — | $1.43B — | 0 | -$3.37 — | |
| Liquidia LQDA | $15.75 — |
+3.21
|
$1.34B — | $1.05M — | $15.34 — | $16.27 — | $1.34B — | 0 | -$1.66 — | |
| Celldex Therapeutics CLDX | $20.18 — |
+10.09
|
$1.34B — | $955.83K — | $19 — | $20.42 — | $1.34B — | 0 | -$2.45 — | |
| 89bio ETNB | $8.11 — |
+5.32
|
$1.18B — | $1.3M — | $8 — | $8.45 — | $1.18B — | 0 | -$3.46 — | |
| Ocular Therapeutix OCUL | $7.39 — |
+4.67
|
$1.18B — | $1.29M — | $7.22 — | $7.65 — | $1.18B — | 0 | -$1.11 — | |
| Innoviva INVA | $18.61 — |
+0.27
|
$1.17B — | $546.03K — | $18.48 — | $18.72 — | $1.17B — | 51.69 | $0.36 — | |
| Aurinia Pharmaceuticals AUPH | $8.12 — |
+1.5
|
$1.11B — | $2.15M — | $7.97 — | $8.39 — | $1.11B — | 203.00 | $0.04 — | |
| MiMedx MDXG | $7.25 — |
+2.84
|
$1.07B — | $892.38K — | $7 — | $7.34 — | $1.07B — | 26.85 | $0.27 — | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||